Avaca Pharma Private Limited - Due diligence report

A 360° intelligence report on Avaca Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and di…

2016-10-07 Guntur, Andhra Pradesh Active Unlisted Active Compliant
Share
Connect MCP
AP Avaca Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Avaca Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
77/100
Trust Score
Low Risk

Avaca Pharma Private Limited is assessed as Low Risk with a Trust Score of 77/100. Avaca Pharma Private Limited is an active private limited indian non-government company incorporated in 2016, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 07 Aug 2026 from the latest processed filings. Avaca Pharma Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
77/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 1.42).
  • Externally credit-rated (BB-).

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • 2 active GST registration(s).
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
MAHESH KANDULA 01234567 Director 01/04/2018 6 yrs Approved
APPARSUNDARAM KANDASWAMY 01234567 Director 01/04/2018 6 yrs Approved
SRIDHAR KOGANTI 01234567 Director 01/04/2018 6 yrs Approved
Anshul Jain 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
18 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 75
Growth signals & trust indicators
Latest year revenue grew 2.1x.
Operating for 9 years.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence81/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment67/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view64/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
03 Oct 2025
Director appointed
Anshul Jain (Company Secretary)
30 Sep 2024
Last AGM held
Annual general meeting
29 Sep 2024
Director ceased
SRIDHAR KOGANTI
31 May 2024
Director ceased
NAGENDRA NAIDU NUTANAPATI
31 Mar 2024
Latest balance sheet
Filed with ROC
06 Dec 2023
Director appointed
SRIDHAR KOGANTI (Director)
01 Oct 2020
Director ceased
MAHESH KANDULA
01 Aug 2020
Director ceased
JITENDER SINGH RATHI
27 Jul 2020
Director ceased
SEETHA RAMAIAH KANKANALA
Director ceased
CHIRUKURI KUMAR RAMANA
18 Jul 2020
Director appointed
APPARSUNDARAM KANDASWAMY (Director)
04 Jul 2020
Director appointed
MAHESH KANDULA (Director)
09 Jun 2020
Director ceased
BABU JOSE PAZHAYATTIL
04 Mar 2020
Securities allotted
30000 Equity Shares Without Differential Rights - 3.00 Lakh raised
25 Feb 2020
Securities allotted
30000 Equity Shares Without Differential Rights - 3.00 Lakh raised
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of BB- from Care.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Capital has been raised through 18 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Samcon Chemicals Private Limited U24231GJ1996PTC029342 Ahmedabad, Gujarat, India
Range Polymers Private Limited U24100MH1997PTC108421 Navi Mumbai, Maharashtra, India
United Tex Chem Solutions Private Limited U24299GJ2020PTC117911 Ahmedabad, Gujarat, India
Involute Engineering Private Limited U74899DL1993PTC054814 Delhi, Delhi, India
Scikem Pharmaceuticals Private Limited U24299TG2017PTC115917 Hydertabad, Telangana, India
Mirth Capital And Finlease Limited U24231DL1996PLC076506 New Delhi, Delhi, India
Arnish Laborates Private Limited U74995MH2018PTC311689 Mumbai, Maharashtra, India
Highgrow Floris Chemicals Private Limited U24119TG2002PTC038348 Saroornagar, Telangana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Avaca Pharma Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Avaca Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 60/100, margin trends, ownership structure and peer set for Avaca Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 77/100, distress signals and MSME payment-delay disclosures - know whether Avaca Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Avaca Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Avaca Pharma Private Limited an active company?

Avaca Pharma Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Avaca Pharma Private Limited financially healthy?

Avaca Pharma Private Limited has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Avaca Pharma Private Limited?

Its overall Trust Score is 77/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Avaca Pharma Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Avaca Pharma Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Avaca Pharma Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Avaca Pharma Private Limited?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.